The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance to tyrosine kinase inhibitor therapy.

Noboru NakaigawaKeiichi KondoDaiki UenoKazuhiro NamuraKazuhide MakiyamaKazuki KobayashiKoichi ShioiIchiro IkedaTakeshi KishidaTomohiro KanetaRyogo MinamimotoUkihide TateishiTomio InoueMasahiro Yao

Published in: BMC cancer (2017)

UMIN0000008141 , 11 Jun 2012. This trial was retrospectively registered.

Keyphrases

renal cell carcinoma
study protocol
phase iii
clinical trial
phase ii
blood glucose
randomized controlled trial
adipose tissue
bone marrow
metabolic syndrome
smoking cessation